Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 Intranasal Spray for Episodic Migraine Prevention
NCT03488563Phase 2Completed
- Sponsor
- AOBiome
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of B244 in episodic migraine, sponsored by AOBiome. Started Mar 2018; status: completed.
02
Drugs
B244
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT03488563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03488563.